Articles with public access mandates - Susan R. SnyderLearn more
Not available anywhere: 4
Socioeconomic factors affect outcomes in well-differentiated thyroid cancer
WC Swegal, M Singer, E Peterson, HS Feigelson, SA Kono, S Snyder, ...
Otolaryngology--Head and Neck Surgery 154 (3), 440-445, 2016
Mandates: US National Institutes of Health
Cost of OraQuick oral fluid rapid HIV testing at 35 community clinics and community-based organizations in the USA
SD Pinkerton, LM Bogart, D Howerton, S Snyder, K Becker, SM Asch
AIDS care 21 (9), 1157-1162, 2009
Mandates: US National Institutes of Health
Disclosure of s Genetic Risk Variant to Familial Hypercholesterolemia Improves Adherence to Lipid Lowering Therapy
L Jones, N Chen, D Hassen, T Klinger, M McMinn, D Hartzel, D Veenstra, ...
Journal of Clinical Lipidology 14 (4), 563-564, 2020
Mandates: US National Institutes of Health
Providers Prescribing Behavior for Lipid-lowering Therapy after Receiving Patients Positive Genetic Test for Familial Hypercholesterolemia
J Hao, N Chen, D Hassen, T Klinger, M Betts, D Hartzel, D Veenstra, ...
Journal of Clinical Lipidology 14 (4), 572-573, 2020
Mandates: US National Institutes of Health
Available somewhere: 20
Effectiveness of practices to increase timeliness of providing targeted therapy for inpatients with bloodstream infections: a laboratory medicine best practices systematic …
SS Buehler, B Madison, SR Snyder, JH Derzon, NE Cornish, MA Saubolle, ...
Clinical microbiology reviews 29 (1), 59-103, 2016
Mandates: US Department of Energy, US National Institutes of Health
Effectiveness of practices to reduce blood culture contamination: a Laboratory Medicine Best Practices systematic review and meta-analysis
SR Snyder, AM Favoretto, RA Baetz, JH Derzon, BM Madison, D Mass, ...
Clinical biochemistry 45 (13-14), 999-1011, 2012
Mandates: US National Institutes of Health
Effectiveness of practices to reduce blood sample hemolysis in EDs: a laboratory medicine best practices systematic review and meta-analysis
NJ Heyer, JH Derzon, L Winges, C Shaw, D Mass, SR Snyder, P Epner, ...
Clinical biochemistry 45 (13-14), 1012-1032, 2012
Mandates: US National Institutes of Health
Effectiveness of barcoding for reducing patient specimen and laboratory testing identification errors: a Laboratory Medicine Best Practices systematic review and meta-analysis
SR Snyder, AM Favoretto, JH Derzon, RH Christenson, SE Kahn, ...
Clinical biochemistry 45 (13-14), 988-998, 2012
Mandates: US National Institutes of Health
Laboratory medicine best practices: systematic evidence review and evaluation methods for quality improvement
RH Christenson, SR Snyder, CS Shaw, JH Derzon, RS Black, D Mass, ...
Clinical chemistry 57 (6), 816-825, 2011
Mandates: US National Institutes of Health
Cost-effectiveness of population-wide genomic screening for hereditary breast and ovarian cancer in the United States
GF Guzauskas, S Garbett, Z Zhou, SJ Spencer, HS Smith, J Hao, ...
JAMA network open 3 (10), e2022874-e2022874, 2020
Mandates: US National Institutes of Health
Implementing universal Lynch syndrome screening (IMPULSS): protocol for a multi-site study to identify strategies to implement, adapt, and sustain genomic medicine programs in …
AK Rahm, D Cragun, JE Hunter, MM Epstein, J Lowery, CY Lu, ...
BMC health services research 18, 1-11, 2018
Mandates: US National Institutes of Health
Effectiveness of practices for improving the diagnostic accuracy of Non ST Elevation Myocardial Infarction in the Emergency Department: A Laboratory Medicine Best Practices …
C Layfield, J Rose, A Alford, SR Snyder, FS Apple, FM Chowdhury, ...
Clinical biochemistry 48 (4-5), 204-212, 2015
Mandates: US Department of Energy
Cost of rapid HIV testing at 45 US hospitals
SD Pinkerton, LM Bogart, D Howerton, S Snyder, K Becker, SM Asch
AIDS patient care and STDs 24 (7), 409-413, 2010
Mandates: US National Institutes of Health
Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study
AR Chang, M Evans, C Yule, L Bohn, A Young, M Lewis, E Graboski, ...
BMC nephrology 17, 1-9, 2016
Mandates: US National Institutes of Health
Is universal HLA‐B*15:02 screening a cost‐effective option in an ethnically diverse population? A case study of Malaysia
HY Chong, Z Mohamed, LL Tan, DBC Wu, FH Shabaruddin, M Dahlui, ...
British Journal of Dermatology 177 (4), 1102-1112, 2017
Mandates: US National Institutes of Health
Hidden Burden of Electronic Health Record‐Identified Familial Hypercholesterolemia: Clinical Outcomes and Cost of Medical Care
P Patel, Y Hu, A Kolinovsky, Z Geng, J Ruhl, S Krishnamurthy, ...
Journal of the American Heart Association 8 (13), e011822, 2019
Mandates: American Heart Association
Cost-effectiveness of population-wide genomic screening for Lynch syndrome in the United States
GF Guzauskas, S Jiang, S Garbett, Z Zhou, SJ Spencer, SR Snyder, ...
Genetics in Medicine 24 (5), 1017-1026, 2022
Mandates: US National Institutes of Health
Generic cost-effectiveness models: a proof of concept of a tool for informed decision-making for public health precision medicine
SR Snyder, J Hao, LH Cavallari, Z Geng, A Elsey, JA Johnson, ...
Public health genomics 21 (5-6), 217-227, 2019
Mandates: US National Institutes of Health
Economic evaluation of universal Lynch syndrome screening protocols among newly diagnosed patients with colorectal cancer
J Hao, D Hassen, JM Gudgeon, SR Snyder, H Hampel, MS Williams, ...
Journal of Personalized Medicine 11 (12), 1284, 2021
Mandates: US National Institutes of Health
Cost-effectiveness analysis of genotyping for HLA-B*15:02 in Indonesian patients with epilepsy using a generic model
R Yuliwulandari, JG Shin, E Kristin, FD Suyatna, ID Prahasto, K Prayuni, ...
The pharmacogenomics journal 21 (4), 476-483, 2021
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program